Ptc Therapeutics (PTCT) Net Cash Flow (QoQ) (2012 - 2026)
Ptc Therapeutics (PTCT) Net Cash Flow (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Ptc Therapeutics | 6.47 Bn | 4.58 Bn | 244.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -148.43% |
| Dec 31, 2025 | 188.71% |
| Sep 30, 2025 | 28.48% |
| Jun 30, 2025 | -168.53% |
| Mar 31, 2025 | 163.14% |
| Dec 31, 2024 | 292.42% |
| Sep 30, 2024 | -225.84% |
| Jun 30, 2024 | 350.07% |
| Mar 31, 2024 | -110.25% |
| Dec 31, 2023 | 1,144.75% |
| Sep 30, 2023 | -109.94% |
| Jun 30, 2023 | 64.30% |
| Mar 31, 2023 | -132.10% |
| Dec 31, 2022 | 507.25% |
| Sep 30, 2022 | -299.28% |
| Jun 30, 2022 | 144.23% |
| Mar 31, 2022 | -1,345.86% |
| Dec 31, 2021 | -77.03% |
| Sep 30, 2021 | -43.00% |
| Jun 30, 2021 | 147.83% |